Fiscal Year 2026 Flood Mitigation Assistance Swift Current
FMA Swift Current aims to better align the delivery of FMA flood mitigation funding to the disaster survivor experience. Offered by Department of Homeland Security - FEMA; awards $600.0M; applications due January 31, 2028.
Key Facts
- Funder
- Department of Homeland Security - FEMA
- Award amount
- $600.0M
- Deadline
- January 31, 2028
- Geography
- United States
- Status
- Open
About This Grant
FMA Swift Current aims to better align the delivery of FMA flood mitigation funding to the disaster survivor experience. The FMA grant program makes federal funds available to states, U.S. territories, federally recognized Indian/Native American Tribal Governments, and local governments to reduce or eliminate the risk of repetitive flood damage to buildings and structures insured under the National Flood Insurance Program (NFIP), and within NFIP-participating communities. FMA funds a...
Full requirements and application instructions: official listing.
Similar Open Grants
Fiscal Year 2026 Next Generation Warning System Grant Program
Department of Homeland Security - FEMA
Fiscal Year 2026 National Incident Management System (NIMS)
Department of Homeland Security - FEMA
Fiscal Year 2026 National Earthquake Hazards Reduction Program Multi-State and National Earthquake Assistance
Department of Homeland Security - FEMA
Fiscal Year 2026 National Earthquake Hazards Reduction Program Individual State Earthquake Assistance
Department of Homeland Security - FEMA
Fiscal Year 2026 State Fire Training Systems Grants
Department of Homeland Security - FEMA
National Cybersecurity Preparedness Consortium
Department of Homeland Security - FEMA
NDEP STEM Open NFO
Washington Headquarters Services
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
WaterSMART Cooperative Watershed Management Program
Bureau of Reclamation
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
National Institutes of Health